Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Notified -...

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

Notified -...

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

...

BioMed X Launches New T Cell Immunology Discovery Platform

BioMed X Launches New T Cell Immunology Discovery Platform

...

menu
menu